Lymphoma - Hodgkin - Childhood

Hodgkin Lymphoma | Dr. Tony Talebi discusses the Treatment of Stage 1-2 Hodgkin Lymphoma
Hodgkin Lymphoma | Dr. Tony Talebi discusses the Treatment of Stage 1-2 Hodgkin Lymphoma administrator 0 Views • 2 years ago

Dr. Tony Talebi discusses the Treatment of Stage 1-2 Hodgkin Lymphoma with Dr Morhbacher. For further information visit http://www.HemOnc101.com


Dr. Talebi's practice, Miami Hematology and Oncology Associates is located at 151 NW 11th street, Suite W303. Homestead, Fl 33030. Tel 786-504-3084

Hodgkin lymphoma


Hodgkin lymphoma accounts for approximately 10 percent of all lymphomas and approximately 0.6 percent of all cancers diagnosed in the developed world annually. This amounts to approximately 8830 new cases and about 1300 deaths due to HL in the United States annually.

The majority of patients with classical Hodgkin lymphoma present with painless localized enlarged lymph nodes, typically involving the cervical (neck) region.


Hodgkin lymphoma arises from germinal center or post-germinal center B cells in the lymph nodes. Hodgkin lymphoma has a unique cellular composition, containing a minority of neoplastic cells (Reed-Sternberg cells and their variants) in an inflammatory background. It is separated from the other B cell lymphomas based on its unique clinicopathologic features, and can be divided into two major sub-groups, based on the appearance and immunophenotype of the tumor cells.

The diagnosis of Hodgkin lymphoma is made by the evaluation of involved tissue, usually a lymph node biopsy. Excisional biopsies are preferred and large core needle biopsies may be adequate in select cases.



Here, Dr. Tony Talebi discusses the general concepts of Hodgkin lymphoma with Dr. Ann Morhbacher, associate professor of medicine at the University of Southern California and a "top US doctor" as per US world news and world report magazine. The discussion includes symptoms, diagnosis, staging, genetic implications, secondary cancers and treatment of hodgkin lymphoma.



Dr. Ann Morhbacher credentials:

Title:

Associate Professor of Clinical Medicine

Locations:

University of Southern California (USC) Norris Comprehensive Cancer Center

Specialties:

Hematology and Oncology

Background:

Dr. Mohrbacher, a graduate of Harvard Medical School, is a devoted educator, researcher and medical practitioner. She has several hematology related research interests and activities, including bone marrow transplantation, and has received thousands of dollars in research grants. She has been published in a number of medical journals and has been invited to lecture on topics including Radioimmunotherapy of non-Hodgkin's lymphoma and B-cell targeted therapy of rheumatoid arthritis. Dr. Mohrbacher is a member of the Southern California Lymphoma Group and currently belongs to a number of university related committees, such as the Post-Graduate Education Committee and the Clinical Investigations Committee.

Education:

Harvard and Radcliffe Colleges, Boston, MA, B.A., 1983
Doctor of Medicine, Harvard Medical School, Boston, MA, 1987
Internships:

Brigham and Women's Hospital, Boston, MA, 1983 - 1984
Residencies:

Brigham and Women's Hospital (Internal Medicine), Boston, MA, 1987 - 1990
Fellowships:

Clinical Medicine Fellow, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 1990 - 1993
Clinical Oncology and Tumor Immunology Fellow, Dana-Farber Cancer Institute, Boston, MA, 1990 - 1993
Board Certification:

Medical Oncology
Internal Medicine
Professional Society Memberships:

Massachusetts Medical Society, 1985
American Society of Hematology, 1994
Southwest Oncology Group, 1994
Awards:

A.B. Magna Cum Laude, 1983
Harvard College Scholarship, 1983
ASCO career Development Award, 1995
Dr. Mohrbacher was voted a Top Doctor by Pasadena Magazine in 2011.

Bhupendra Tripathi's Non--Hodgkin’s Lymphoma Survivor Story Pt-2 | Onco.com
Bhupendra Tripathi's Non--Hodgkin’s Lymphoma Survivor Story Pt-2 | Onco.com administrator 0 Views • 2 years ago

At the start of his cancer treatment, a very complex spine surgery
was scheduled. The doctors opined that even if the spine surgery was
successful, Bhupendra may never be able to walk again. Bhupendra
remembers telling his mother that he didn’t want to be a ‘burden’ on
anyone. He didn’t want to be wheelchair bound for the rest of his
life.

His mother explained to him that he had always made his parents proud,
be it during his school days or career. He had always given them
many occasions to be joyful. And she was certain that in future too,
he would keep on giving them many chances to rejoice. Her loving
words pumped courage in Bhupendra’s bloodstream

Through this journey, Bhupendra lost much. Years were lost to
treatment, and he eventually also lost his complete eyesight. But
amazingly, all these setbacks did not deter him from his habit of
winning! He survived and is now living proof that even stage IV cancer can be defeated.

Watch this video to know more about his inspiring cancer journey and how he is truly a cancer winner!

'Suffering is Optional' : Bhupendra Tripathi | Story of a Non-Hodgkin’s Lymphoma Survivor Pt-1 :
https://youtu.be/Xa9pns99L1s

#CancerSurvivor #SurvivorStories #NonHodgkinsLymphoma

#FightCancerWithOnco
If you, or a loved one, have been diagnosed with cancer recently, and have questions or require guidance on cancer care, download the Onco Cancer Care App today! https://onco-app.onco.com/8WPu/care
Available on AppStore and Google Play

Connect with us:
Call: 79965 79965
Website: https://onco.com/
Facebook: facebook.com/OncoDotCom/
Instagram: instagram.com/oncodotcom/
Twitter: twitter.com/OncoDotCom

Bhupendra Tripathi's YouTube Channel Link: https://www.youtube.com/user/btripathi81

Hodgkins Lymphoma Pathophysiology, symptoms and treatment
Hodgkins Lymphoma Pathophysiology, symptoms and treatment administrator 2 Views • 2 years ago

Hodgkins lymphoma is a neoplasm of the immune system that is marked by the presence of a type of cell called the Reed-Sternberg cell.

The two major types of Hodgkin lymphoma are classical Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma.

Classic Hodgkin lymphoma
Classic Hodgkin lymphoma (cHL) accounts for more than 9 in 10 cases of Hodgkin
lymphoma in developed countries.
The cancer cells in cHL are called Reed-Sternberg cells. These cells are usually an
abnormal type of B lymphocyte. Enlarged lymph nodes in people with cHL usually have
a small number of Reed-Sternberg cells with a lot of normal immune cells around them.
These other immune cells cause most of the swelling in the lymph nodes.
Classic HL has 4 subtypes:

nodular sclerosis Hodgkin lymphoma or NSCHL: This is the most common type
of Hodgkin disease in developed countries. It accounts for about 7 out of 10 cases.
It's most common in teens and young adults, but it can occur in people of any age.
It tends to start in lymph nodes in the neck or chest.

Mixed cellularity Hodgkin lymphoma or MCCHL: This is the second most
common type, found in about 4 out 10 cases. It's seen mostly in people with HIV
infection. It's also found in children or the elderly . It can start in any lymph node but
most often occurs in the upper half of the body.

Lymphocyte-rich Hodgkin lymphoma: This sub-type isn't common. It usually
occurs in the upper half of the body and is rarely found in more than a few lymph
nodes.

Lymphocyte-depleted Hodgkin lymphoma: This is a rare form of Hodgkin
disease. It's seen mainly in older people and those with HIV infection. It's more
aggressive than other types of HL and likely to be advanced when first found. It's
most often in lymph nodes in the abdomen (belly) as well as in the spleen, liver, and
bone marrow.

Nodular lymphocyte-predominant Hodgkin lymphoma
Nodular lymphocyte-predominant Hodgkin lymphoma accounts for about 5%
of cases. The cancer cells in NLPHL are large cells called popcorn cells (because they
look like popcorn), which are variants of Reed-Sternberg cells. You may also hear these
cells called lymphocytic and histiocytic (L&H) cells.
NLPHL usually starts in lymph nodes in the neck and under the arm. It can occur in
people of any age, and is more common in men than in women. This type of HL tends
to grow more slowly and is treated differently from the classic types.
Symptoms include the painless enlargement of lymph nodes, spleen, or other immune tissue. Other symptoms include fever, weight loss, fatigue, or night sweats. Also called Hodgkin disease.

Nivolumab + chemotherapy in previously untreated stage III or IV Hodgkin lymphoma
Nivolumab + chemotherapy in previously untreated stage III or IV Hodgkin lymphoma administrator 0 Views • 2 years ago

[Oncoinfo – Istantanee di Oncologia: seguici su http://oncoinfo.it] The SWOG S1826 trial could change the treatment of classic Hodgkin lymphoma forever. Why and how? We asked Alex Francisco Herrera (Associate Professor, Division Of Lymphoma - City of Hope National Medical Center, Duarte) at ASCO 2023, in Chicago. He explained us how N-AVD improved PFS vs BV-AVD in pts with AS HL.

Showing 4 out of 5